skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Application of reticulated platelets to transfusion management during autologous stem cell transplantation

Short Report

(957) Views  (213) Full article downloads

Authors: Parco S, Vascotto F

Published Date January 2012 Volume 2012:5 Pages 1 - 5
DOI: http://dx.doi.org/10.2147/OTT.S27883

Sergio Parco, Fulvia Vascotto

Institute for Maternal and Child Health – IRCCS Burlo Garofolo, Trieste, Italy

Background: The immature (or reticulated) platelet fraction (IPF) is rich in nucleic acids, especially RNA, and can be used as a predictive factor for platelet recovery in platelet immunomediated consumption or in postchemotherapy myelosuppression. Our aim was to determine if transfusions with IPF-rich solutions, during autologous peripheral blood stem cell transplantation, reduce the occurrence of bleeding and hemorrhagic complications.
Patients and methods: Transfusions were administered to 40 children, affected with hematological pathologies, who underwent autologous peripheral hematopoietic progenitor cell transplantation. There were two groups of 20 patients, one group treated with IPF-poor and the other with IPF-rich solutions. In the two groups, the conditioning regimen was the same for the same pathology (hematological pathologies: 14 acute lymphoblastic leukemia; twelve acute myelocytic leukemia; four non-Hodgkin's lymphoma; two Hodgkin's lymphoma; eight solid tumors). A new automated analyzer was used to quantify the IPF: the XE2100 (Sysmex, Kobe, Japan) blood cell counter with upgraded software.
Results: The 20 patients who received solutions with a high percentage of IPF (3%–9% of total number of infused platelets) required fewer transfusions than the 20 patients who received transfusions with a low percentage of IPF (0%–1% of total number of infused platelets): 83 versus 129 (mean of number of transfusions 4.15 versus 6.45) and a significant difference was found between the two groups by using the Mann–Whitney test (P < 0.001). The prophylactic transfusions decreased from three to two per week. There was only one case of massive hemorrhage.
Conclusion: The use of IPF solutions reduces the number of transfusions and bleedings after peripheral blood stem cell transplantation in pediatric patients.

Keywords: children, reticulated platelet fraction, transfusion management, hemorrhage





 

Other articles by Dr Sergio Parco



Readers of this article also read:

Development and validation of an RNAi screen for ABT-737 sensitizers
Public optimism towards nanomedicine
Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiation
Emerging treatment options for the treatment of neuroblastoma: potential role of perifosine
Targeted agents for the treatment of metastatic melanoma
Hedgehog pathway as a drug target: Smoothened inhibitors in development
Treatment of advanced pancreatic neuroendocrine tumors: potential role of everolimus
Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles
Vorinostat approved in Japan for treatment of cutaneous T-cell lymphomas: status and prospects
Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatment